---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-072272"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:04:14.293656+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Supernus annual meeting results: directors elected, equity plan increase approved

## Summary
- Class III directors Georges Gemayel and Bethany Sensenig elected with ~48.4M and ~48.6M votes for, respectively.
- Say-on-pay proposal approved with 48.2M for, 2.3M against, 1.9M broker non-votes.
- Ratification of KPMG as auditor passed with 52.2M for, 272.9K against; no broker non-votes.
- Amendment to 2021 Equity Incentive Plan to increase shares passed with 45.5M for, 5.0M against, 1.9M broker non-votes.

## SEC filing metadata
- accession: 0001104659-24-072272
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000110465924072272/0001104659-24-072272-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000110465924072272/tm2417381d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-072272
- JSON: https://secwatch.observer/filing/0001104659-24-072272.json
- Plain text: https://secwatch.observer/filing/0001104659-24-072272.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.